艾德生物
(300685)
| 流通市值：90.74亿 | | | 总市值：91.19亿 |
| 流通股本：3.90亿 | | | 总股本：3.92亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,037,365,789.66 | 984,160,214.99 | 876,734,780.23 | 828,873,935.82 |
| 交易性金融资产 | 277,652,676.1 | 242,347,632.37 | 382,699,868.39 | 351,885,744.55 |
| 应收票据及应收账款 | 617,107,027.55 | 617,275,719.79 | 556,814,017.83 | 542,105,519.22 |
| 其中：应收票据 | 20,551,644.74 | 20,630,271.31 | 20,615,148.54 | 15,856,231.01 |
| 应收账款 | 596,555,382.81 | 596,645,448.48 | 536,198,869.29 | 526,249,288.21 |
| 预付款项 | 11,089,948.92 | 13,345,315.03 | 18,674,289.46 | 12,851,955.47 |
| 其他应收款合计 | 2,920,149.19 | 1,980,766.64 | 2,473,417.5 | 2,348,321.53 |
| 存货 | 43,081,908.34 | 41,873,616.88 | 34,636,347.03 | 34,365,482.01 |
| 合同资产 | 1,406,573.39 | 1,981,849.06 | 1,024,058.17 | 1,192,823.51 |
| 一年内到期的非流动资产 | - | 5,592,987.16 | 5,457,706.54 | 5,322,425.92 |
| 其他流动资产 | 5,054,586.08 | 11,451,428.05 | 12,907,401.49 | 9,453,688.74 |
| 流动资产合计 | 1,995,678,659.23 | 1,920,009,529.97 | 1,891,421,886.64 | 1,788,399,896.77 |
| 非流动资产: | | | | |
| 长期应收款 | - | 12,405,529.02 | 12,263,822.58 | 12,122,116.14 |
| 长期股权投资 | 4,506,067.17 | 10,950,220.1 | 10,497,291.81 | 11,951,810.18 |
| 固定资产 | 164,217,016.25 | 165,304,163.63 | 170,749,929.32 | 173,256,020.58 |
| 使用权资产 | 10,131,894.73 | 11,312,403.5 | 11,837,434.89 | 12,997,943.06 |
| 无形资产 | 41,348,254.55 | 43,478,998.79 | 45,285,167.34 | 43,582,741.36 |
| 长期待摊费用 | 6,350,602.04 | 3,052,122.69 | 3,524,161.46 | 4,736,367.84 |
| 递延所得税资产 | 14,083,741.18 | 11,148,052.24 | 11,064,822.26 | 10,060,623.33 |
| 其他非流动资产 | 9,859,309.5 | 16,161,736.68 | 6,868,313 | 7,694,191.8 |
| 非流动资产合计 | 250,496,885.42 | 273,813,226.65 | 272,090,942.66 | 276,401,814.29 |
| 资产总计 | 2,246,175,544.65 | 2,193,822,756.62 | 2,163,512,829.3 | 2,064,801,711.06 |
| 流动负债: | | | | |
| 短期借款 | 5,004,109.59 | 5,000,000 | - | - |
| 应付票据及应付账款 | 19,991,658.33 | 30,043,052.22 | 23,171,478.76 | 19,702,291.87 |
| 应付账款 | 19,991,658.33 | 30,043,052.22 | 23,171,478.76 | 19,702,291.87 |
| 预收款项 | 26,990 | 48,790 | - | 84,640 |
| 合同负债 | 4,044,113.47 | 2,936,803.16 | 3,669,048.13 | 4,281,980.76 |
| 应付职工薪酬 | 51,903,772.54 | 57,134,609.33 | 46,308,003.48 | 39,558,744.29 |
| 应交税费 | 36,580,099.98 | 43,930,240.04 | 42,724,154.59 | 25,332,940.67 |
| 其他应付款合计 | 58,343,487.79 | 81,242,785.44 | 54,358,251.52 | 57,290,286.04 |
| 应付股利 | - | 23,679,436.32 | - | - |
| 一年内到期的非流动负债 | 6,702,818.61 | 4,590,311.6 | 48,790,761.52 | 48,523,955.23 |
| 其他流动负债 | 128,777.9 | 98,581.63 | 178,849.05 | 47,739.86 |
| 流动负债合计 | 182,725,828.21 | 225,025,173.42 | 219,200,547.05 | 194,822,578.72 |
| 非流动负债: | | | | |
| 长期借款 | 82,684,643.84 | 58,832,876.71 | - | - |
| 租赁负债 | 7,141,243.48 | 8,487,149.67 | 7,837,091.1 | 8,732,314.17 |
| 递延收益 | 14,630,284.37 | 15,814,374.89 | 17,628,217.61 | 17,982,060.31 |
| 递延所得税负债 | 71,414.33 | - | - | - |
| 非流动负债合计 | 104,527,586.02 | 83,134,401.27 | 25,465,308.71 | 26,714,374.48 |
| 负债合计 | 287,253,414.23 | 308,159,574.69 | 244,665,855.76 | 221,536,953.2 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 391,536,144 | 391,536,144 | 393,061,969 | 398,436,809 |
| 资本公积 | 122,083,374.87 | 122,343,577.15 | 136,956,196.36 | 232,079,474.86 |
| 减:库存股 | 33,280,362.28 | 33,267,132.28 | 34,380,996.78 | 120,438,010.16 |
| 其他综合收益 | 2,249,654.86 | 2,199,060.22 | 2,045,483.62 | 2,142,884.84 |
| 盈余公积 | 149,842,444.59 | 149,842,444.59 | 149,842,444.59 | 149,842,444.59 |
| 未分配利润 | 1,326,490,874.38 | 1,253,009,088.25 | 1,271,321,876.75 | 1,181,201,154.73 |
| 归属于母公司股东权益合计 | 1,958,922,130.42 | 1,885,663,181.93 | 1,918,846,973.54 | 1,843,264,757.86 |
| 股东权益合计 | 1,958,922,130.42 | 1,885,663,181.93 | 1,918,846,973.54 | 1,843,264,757.86 |
| 负债和股东权益合计 | 2,246,175,544.65 | 2,193,822,756.62 | 2,163,512,829.3 | 2,064,801,711.06 |
| 公告日期 | 2025-10-25 | 2025-07-29 | 2025-04-22 | 2025-04-22 |
| 审计意见(境内) | | | | 标准无保留意见 |